Patents Assigned to Alligator Bioscience AB
  • Patent number: 7282334
    Abstract: The invention provides a method for generating a polynucleotide sequence or population of sequences from parent single stranded polynucleotide sequences encoding one or more protein motifs, comprising the steps of a) providing single stranded DNA constituting plus and minus strands of parent polynucleotide sequences; b) digesting the single stranded polynucleotide sequences with a nuclease other than DNase I to generate populations of single stranded fragments; c) contacting said fragments generated from the plus strands with fragments generated from the minus strands and optionally, adding primer sequences that anneal to the 3? and 5? ends of at least one of the parent polynucleotides under annealing conditions; d) amplifying the fragments that anneal to each other to generate at least one polynucleotide sequence encoding one or more protein motifs having altered characteristics as compared to the one or more protein motifs encoded by said parent polynucleotides.
    Type: Grant
    Filed: July 20, 2005
    Date of Patent: October 16, 2007
    Assignee: Alligator Bioscience, AB
    Inventors: Roland Carlsson, Ann-Christin Malmborg Hager, Christina Furebring, Carl Borrebaeck
  • Patent number: 7262012
    Abstract: A method for in vitro molecular evolution of protein function The invention provides a method for generating a polynucleotide sequence or population of sequences from parent single-stranded polynucleotide sequences encoding one or more protein motifs, comprising the steps of (a) providing a first population of single-stranded polynucleotide molecules and a second population of single-stranded polynucleotide molecules, the first and second populations together constituting plus and minus strands of parent polynucleotide sequences, (b) carrying out a reaction for digesting the first and second populations of single-stranded polynucleotide molecules with an exonuclease to generate corresponding populations of single-stranded polynucleotide fragments, (c) contacting said fragments generated from the plus strands with fragments generated from the minus strands and optionally, adding primer sequences that anneal to the 3? and 5?ends of at least one of the parent polynucleotides under annealing conditions, and (d) a
    Type: Grant
    Filed: May 16, 2003
    Date of Patent: August 28, 2007
    Assignee: Alligator Bioscience AB
    Inventors: Christina Furebring, Roland Carlsson, Carl Arne Krister Borrebaeck, Ann-Christin Malmborg Hager
  • Patent number: 7153655
    Abstract: The present invention relates to a method for in vitro evolution of protein function. In particular, the method relates to the shuffling of nucleotide segments obtained from exonuclease digestion. The present inventors have shown that polynucleotide fragments derived from a parent polynucleotide sequence digested with an exonuclease can be combined to generate a polynucleotide sequence which encodes for a polypeptide having desired characteristics. This method may be usefully applied to the generation of new proteins (e.g., antibodies and enzymes) or parts thereof having modified characteristics as compared to the parent protein.
    Type: Grant
    Filed: December 17, 2002
    Date of Patent: December 26, 2006
    Assignee: Alligator Bioscience AB
    Inventors: Carl Arne Krister Borrebaeck, Ann-Christin Malmborg-Hager, Christina Furebring, Ulf Hans Eskil Soderlind, Rebecka Ingrid Camilla Ottosson
  • Publication number: 20060166198
    Abstract: A method for in vitro molecular evolution of protein function The invention provides a method for generating a polynucleotide sequence or population of sequences from parent single-stranded polynucleotide sequences encoding one or more protein motifs, comprising the steps of (a) providing a first population of single-stranded polynucleotide molecules and a second population of single-stranded polynucleotide molecules, the first and second populations together constituting plus and minus strands of parent polynucleotide sequences, (b) carrying out a reaction for digesting the first and second populations of single-stranded polynucleotide molecules with an exonuclease to generate corresponding populations of single-stranded polynucleotide fragments, (c) contacting said fragments generated from the plus strands with fragments generated from the minus strands and optionally, adding primer sequences that anneal to the 3? and 5?ends of at least one of the parent polynucleotides under annealing conditions, and (d) a
    Type: Application
    Filed: May 16, 2003
    Publication date: July 27, 2006
    Applicant: Alligator Bioscience AB
    Inventors: Christina Furebring, Roland Carlsson, Carl Borrebaeck, Ann-Christin Malmborg Hager
  • Patent number: 7081513
    Abstract: The invention relates to nucleic acid molecules encoding (poly)peptides having chemotaxis inhibiting (poly)peptides CHIPS activity, to recombinant vectors harboring such molecules, and the host cells carrying the vectors. The invention further relates to methods for preparing recombinant (poly)peptides having CHIPS activity and to the use of such recombinant (poly)peptides having CHIPS activity for diagnosis, prophylaxis and treatment, such as the treatment of inflammation reactions and HIV. In addition, the invention provides therapeutic and diagnostic compositions comprising as the active ingredient the (poly)peptide having CHIPS activity.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: July 25, 2006
    Assignee: Alligator Bioscience AB
    Inventors: Johannes Antonius Gerardus Van Strijp, Cornelis Petrus Maria Van Kessel, Andreas Paul Peschel
  • Patent number: 6958213
    Abstract: The invention provides a method for generating a polynucleotide sequence or population of sequences from parent single stranded polynucleotide sequences encoding one or more protein motifs, comprising the steps of (a) providing single stranded DNA constituting plus and minus strands of parent polynucleotide sequences; (b) digesting the single stranded polynucleotide sequences with a nuclease other than DNase I to generate populations of single stranded fragments; (c) contacting said fragments generated from the plus strands with fragments generated from the minus strands and optionally, adding primer sequences that anneal to the 3? and 5? ends of at least one of the parent polynucleotides under annealing conditions; (d) amplifying the fragments that anneal to each other to generate at least one polynucleotide sequence encoding one or more protein motifs having altered characteristics as compared to the one or more protein motifs encoded by said parent polynucleotides.
    Type: Grant
    Filed: December 12, 2000
    Date of Patent: October 25, 2005
    Assignee: Alligator Bioscience AB
    Inventors: Roland Carlsson, Ann-Christin Malmborg Hager, Christina Furebring, Carl Borrebaeck
  • Publication number: 20050143307
    Abstract: The present invention relates to a new protein of the bacteria Straphylococcus aureus with immunomodulating properties. The invention further relates to the manufacture of a therapeutic composition as general inflammation inhibitor and for the treatment of AIDS, and also the use of antibodies against CHIPS for the treatment of Staphylococcus infections.
    Type: Application
    Filed: February 22, 2005
    Publication date: June 30, 2005
    Applicant: Alligator Bioscience AB
    Inventors: Johannes Antonius Gerardus Van Strijp, Cornelis Petrus Maria Van Kessel